California Nanotechnologies Announces Stock Options

California Nanotechnologies Corp. (TSXV: CNO) (OTCID: CANOF), based in Los Angeles, has announced the granting of 2,475,000 incentive stock options to its employees, directors, and officers. This action, approved by the Board of Directors on October 15, 2025, aligns with the Company’s Stock Option Plan. The options are set at an exercise price of $0.39 CAD per share, matching the most recent closing price of the stock. They are designed to vest over a three-year period and will expire after five years, in accordance with the requirements of the TSX Venture Exchange.

California Nanotechnologies aims to revolutionize product innovation through its advanced technologies, particularly in processing metallurgic powders. Trusted by global leaders across various industries, the Company plays a crucial role in pushing the boundaries of applied material science. With an operation that encompasses two manufacturing facilities in Greater Los Angeles, Cal Nano is well-equipped to address the materials research and production needs of clients ranging from Fortune 500 companies to emerging startups. Their work spans diverse sectors including aerospace, renewable energy, defense, and semiconductors.

For further inquiries or information, Eric Eyerman serves as the CEO of California Nanotechnologies Corp. and can be contacted directly. Additionally, Panolia Investor Relations Inc., led by Brandon Chow, is available for investor-related communication.

This stock options grant is noteworthy as it reflects the Company’s commitment to incentivizing its team while aligning their interests with the long-term growth of California Nanotechnologies. As the market continues to evolve, such strategic measures are essential for enhancing employee retention and boosting overall company performance.

California Nanotechnologies Corp. (TSXV: CNO) recently announced the granting of 2,475,000 stock options to its employees, directors, and officers, setting the exercise price at $0.39 CAD per share, aligned with the current market closing price. This strategic move underscores the company’s commitment to retaining talent and incentivizing leadership, thereby strengthening its operational capabilities.

From a market perspective, granting stock options can be seen as a double-edged sword: it dilutes existing shareholders’ equity while aligning interests among employees and management. However, in this case, the long vesting period over three years demonstrates a focus on sustained performance and could positively impact company culture. Investors should note this alignment as a potentially bullish sign for Cal Nano’s future growth trajectory.

Despite the potential short-term dilution fears, the core business model and innovative prowess of California Nanotechnologies in metallurgic processing remain robust and appealing for long-term investors. The sectors they serve—such as aerospace, renewable energy, and semiconductors—are aligned with growing market trends towards advanced materials and sustainability.

Moreover, the stable financial backing from prominent clients, including Fortune 500 companies, indicates a solid foundation that can weather economic fluctuations. Investors should consider the current stock price in relation to the exercise price when analyzing the options' potential impact. At $0.39 CAD, the options present a favorable entry point for employees that may correlate with increased dedication to driving company performance.

In conclusion, while there may be initial concerns regarding dilution, the stock option grant reflects a strategic investment in human capital that can yield returns over time. Investors are encouraged to watch Cal Nano’s performance closely and consider the long-term growth potential in an expanding market.